Back

Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Acute coronary syndrome treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)

12 More presentations in this session

Presentation thumbnail
Doctor A. Mishra (Sayre, US)
Abstract Slides
Presentation thumbnail
Doctor P. Azevedo (Faro, PT)
Abstract Slides
Presentation thumbnail
Doctor H. Tashiro (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Doctor Q. Deng (Wuhan, CN)
Presentation thumbnail
Professor R. Dabrowski (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Acute coronary syndrome treatment

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients
7 April 2022
thumbnail
Congress Presentation
An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates
2 September 2024
thumbnail
Congress Presentation
Association of baseline and longitudinal changes in non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in peripheral artery disease
30 August 2025
thumbnail
Congress Presentation
Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources